ArticleiScience2023

FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants.

Robert Meineke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.